TRDA is currently covered by 2 analysts with an average price target of $13. This is a potential upside of $8.65 (198.85%) from yesterday's end of day stock price of $4.35.
Entrada Therapeutics's activity chart (see below) currently has 32 price targets and 33 ratings on display. The stock rating distribution of TRDA is 100% BUY.
Analysts' price targets on this stock were met 24.21% of the time, taking 84 days on average.
Highest price target for TRDA is $13, Lowest price target is $13, average price target is $13.
Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM. First documented stock forecast 23-Nov-2021.
Currently out of the existing stock ratings of TRDA, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2026
$13
$8.65 (198.85%)
$17
3 days ago
(18-Nov-2026)
Buy Since 03-Apr-2023
$20
6 months 13 days ago
(08-May-2026)
4/14 (28.57%)
$8.96 (81.16%)
126
Buy Since 25-Apr-2023
$17
$20
1 years 3 months 14 days ago
(07-Aug-2025)
1/6 (16.67%)
$11.7 (220.75%)
371
Buy Since 04-Jan-2024
$30
$22
1 years 7 months 28 days ago
(24-Mar-2025)
0/2 (0%)
$19.2 (177.78%)
Buy Since 26-Aug-2024
$30
$28
1 years 8 months 24 days ago
(28-Feb-2025)
0/3 (0%)
$18.06 (151.26%)
What is TRDA (Entrada Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TRDA (Entrada Therapeutics)?
Which analyst has the lowest performance score on TRDA (Entrada Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?
Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?
Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?